Vinapamula et al. [27] have found that serum ADA levels were higher in rheumatoid arthritis patients (N = 46) compared to controls (N = 46), which suggested that serum ADA could be as inflammatory marker for rheumatoid arthritis patients. This evidence concerns the gene ADA and rheumatoid arthritis.